Stepwise diagnosis and treatment from uninvestigated dyspepsia to functional dyspepsia in clinical practice in Japan: Proposal of a 4-step algorithm

Digestion

Volumn 79, Issue SUPPL. 1, 2009, Pages 19-25

  Nakajima, Shigemi ^a,b  

^a Social Insurance Shiga Hospital   (Japan)

^b Social Insurance Shiga Hospital   (Japan)

Author keywords

Algorithm; Dyspepsia; Functional gastrointestinal disorder; Gastroesophageal reflux disease; H2 receptor antagonist; Helicobacter pylori; Nonerosive gastroesophageal reflux disease; Prokinetics; Proton pump inhibitor

Indexed keywords

ANTIDEPRESSANT AGENT; CISAPRIDE; DOMPERIDONE; ITOPRIDE; MOSAPRIDE CITRATE; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

ALGORITHM; CLINICAL PRACTICE; CONFERENCE PAPER; DEPRESSION; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DYSPEPSIA; FUNCTION TEST; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HUMAN; JAPAN; METABOLIC DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; ROME III QUESTIONNAIRE; TREATMENT RESPONSE;

ALGORITHMS; DYSPEPSIA; HELICOBACTER INFECTIONS; HUMANS; JAPAN; PROTON PUMP INHIBITORS;

EID: 58549111389     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167862     Document Type: Conference Paper

References (23)

1. Talley NJ; American Gastroenterological Association: American Gastroenterological Association medical position statement: evaluation of dyspepsia. Gastroenterology 2005;129:1753-1755.
2. Talley NJ, Vakil NB, Moayyedi P: American Gastroenterological Association technical review on the evaluation of dyspepsia. Gastroenterology 2005;129:1756-1780.
3. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ: Current concepts in the management of Helicobacter pylori infection: the Maastricht III consensus report. Gut 2007;56:772-781.
4. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, Stanghellini V: Functional gastroduodenal disorders; in Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, Whitehead WE (eds): ROME III: The Functional Gastrointestinal Disorders, ed 3. McLean, Degnon Associates Inc., 2006, pp 419-486.
5. Colin-Jones DG: Management of dyspepsia: report of a working party. Lancet 1988;1:576-579.
6. Ohata H, Kitauchi S, Yoshimura N, Mugitani K, Iwane M, Nakamura H, Yoshikawa A, Yanaoka K, Arii K, Tamai H, Shimizu Y, Takeshita T, Mohara O, Ichinose M: Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-143.
7. Laine L, Estrada R, Trujillo M, Knigge K, Fennerty MB: Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori . Ann Intern Med 1998;129:547-550.
8. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D: Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;2:CD001960.
9. Talley NJ, Hunt RH: What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology 1997;113(suppl 6):S67-S77.
10. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, Oakes R, Wilson S, Roalfe A, Bennett C, Forman D: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;2:CD002096.
11. Nakajima S, Inoue K: Consensus on the requirements in considering eradication therapy to Helicobacter pylori infection for the patients whose diseases are not approved to eradicate by medical insurance. Japn J Helicobacter Res 2007;9:75-76.
12. Fock KM, Talley NJ, Fass R, Goh KL, Katelaris P, Hunt R, Hongo M, Ang TL, Holtmann G, Nandurkar S, Lin SR, Wong BC, Chan FK, Rani AA, Bak YT, Sollano J, Ho KY, Manatsathit S: Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol 2008;23:8-22.
13. Lee KJ, Vos R, Janssens J, Tack J: Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol 2004;286:G278-G284.
14. Bate CM, Riley SA, Chapman RW, Durnin AT, Taylor MD: Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999;13:59-66.
15. Wilson JA, Vela MF: New esophageal function testing (impedance, Bravo pH monitoring, and high-resolution manometry): clinical relevance. Curr Gastroenterol Rep 2008;10:222-230.
16. Thompson WG, Drossman DA, Talley NJ, Walker L, Whitehead WE; Questionnaire Subcomittee: Rome III diagnostic questionnaire for the adult functional GI disorders (including alarm questions) and scoring algorithm; in Drossman DA, Corazziari E, Delvaux M, Spiller RC, Talley NJ, Thompson WG, Whitehead WE (eds): ROME III: The Functional Gastrointestinal Disorders, ed 3. McLean, Degnon Associates Inc., 2006, pp 917-951.
17. Nakajima S, Fujiyama Y: Preliminary evaluation of the Rome III diagnostic questionnaire for the Japanese adult functional gastrointestinal disorders (FGIDs) utilizing the automated analysis program made by the authors. Shoukakan Undou 2008;10:5-8.
18. Drossman DA: The functional gastrointestinal disorders and the Rome II process; in Drossman DA, Corazziari E, Talley NJ, Thompson WG, Whitehead WE (eds): ROME II: The Functional Gastrointestinal Disorders, ed 2. McLean, Degnon Associates Inc., 2000, pp 1-29.
19. Nakajima S: The spectra of functional gastrointestinal disorders (FGIDs) in a Japanese hospital outpatient department according to the ROME II Integrative Questionnaire. J Gastroenterol Hepatol 2008 (suppl), in press.
20. Hiyama T, Yoshihara M, Matsuo K, Kusunoki H, Kamada T, Ito M, Tanaka S, Chayama K, Haruma K: Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 2007;22:1566-1570.
21. Soo S, Moayyedi P, Deeks J, Delaney B, Lewis M, Forman D: Psychological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2005;2:CD002301.
22. Oikawa T, Ito G, Koyama H, Hanawa T: Prokinetic effect of a Kampo medicine, Hangekoboku-to (Banxia-houpo-tang), on patients with functional dyspepsia. Phytomedicine 2005;12:730-734.
23. Tatsuta M, Iishi H: Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1993;7:459-462.